• ‘Fast' MRI shows potential as prostate cancer screening method

    One year ago - By Healio

    MRI improved detection of clinically significant prostate cancer without increasing overdiagnosis compared with PSA testing, according to a prospective, population-based, blinded cohort study published in JAMA Oncology.
    The IP1-PROSTAGRAM study also showed ultrasonography did not improve prostate cancer detection in the general population compared with PSA testing alone.
    “The PSA threshold was set at 3 ng/mL or greater to denote a screen-positive result in line with previous screening trials,” David Eldred-Evans, MBBS, MRCS, senior clinical research fellow at Imperial Prostate,
    Read more ...

     

  • New urine test could avoid unnecessary prostate cancer biopsies

    One year ago - By News Medical

    A urine test based on University of Michigan Rogel Cancer Center research could have avoided one third of unnecessary prostate cancer biopsies while failing to detect only a small number of cancers, according to a validation study that included more than 1,500 patients.
    Read more ...

     

  • Genomic test may help guide treatment decisions for patients with recurrent prostate cancer

    One year ago - By News Medical

    A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may benefit from hormone therapy, according to new research from the Johns Hopkins Kimmel Cancer Center and 15 other medical centers.
    Read more ...